Publicaciones en colaboración con investigadores/as de Mutua de Terrassa (98)

2024

  1. Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study

    Clinical Microbiology and Infection

  2. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

  3. Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study

    Annals of Clinical Microbiology and Antimicrobials, Vol. 23, Núm. 1

  4. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

    Haematologica, Vol. 109, Núm. 2, pp. 543-552

  5. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia

    International Journal of Antimicrobial Agents, Vol. 64, Núm. 2

  6. Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography

    Cardiovascular Revascularization Medicine, Vol. 60, pp. 18-26

  7. Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study

    The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399

2023

  1. Association of Time of Day with Outcomes among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia

    Stroke, Vol. 54, Núm. 3, pp. 770-780

  2. Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort

    Antibiotics, Vol. 12, Núm. 1

  3. Cost analysis of a patient blood management program for patients undergoing gastric cancer surgery

    European Journal of Surgical Oncology, Vol. 49, Núm. 1, pp. 293-297

  4. Data quality validation of the Spanish Incisional Hernia Surgery Registry (EVEREG): pilot study

    Hernia, Vol. 27, Núm. 3, pp. 665-670

  5. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  6. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 229-236

  7. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  8. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study

    Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127

  9. Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study

    Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693

  10. Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study

    Neurologia, Vol. 38, Núm. 6, pp. 412-418

  11. Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia

    European Stroke Journal, Vol. 8, Núm. 2, pp. 557-565

2022

  1. Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020

    Stroke, Vol. 53, Núm. 11, pp. 3289-3294

  2. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

    Blood Advances, Vol. 6, Núm. 4, pp. 1193-1206